Publication | Closed Access

Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin

Breast OncologyCellular InfluxMedicinePharmacologyBreast CancerTumor TargetingAnti-cancer AgentCancer TreatmentOncologyCell BiologyTumor Biology